Diabetes Research and Clinical Practice
Volume 58, Issue 3 , Pages 167-172 , December 2002

Clinical features of a young Japanese woman having marked obesity and abrupt onset of diabetes mellitus with ketoacidosis

Received 30 January 2002 ,Revised 31 May 2002 ,Accepted 17 June 2002.

References 

  1. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int. J. Obes. Relat. Metab. Disord. 1983;7:437–445
  2. Kobayashi J, Tadokoro N, Watanabe M, Shinomiya M. A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int. J. Obes. Relat. Metab. Disord. 2002;26:398–402
  3. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In:  Scriver CR, et al. editor. The Metabolic and Molecular Basis of Inherited Disease. 8th ed.. New York: McGraw Hill; 2000;p. 2789–2816
  4. Ong JM, Kirchgessner TG, Schotz MC, Kern PA. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J. Biol. Chem. 1988;263:12 933–13 938
  5. Semenkovich CF, Wims M, Noe L, Etinne J, Chan L. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J. Biol. Chem. 1989;84:9030–9038
  6. Kobayashi J, Saito K, Fukamachi I, et al.  Pre-heparin plasma lipoprotein lipase mass: its correlation with intra-abdominal visceral fat accumulation. Horm. Metab. Res. 2001;33:412–416
  7. Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K. Pre-heparin serum lipoprotein lipase mass level: the effects of age, gender and type of hyperlipidemia. Atherosclerosis. 1999;145:45–50
  8. Kobayashi J, Maruyama T, Masuda M, Shinomiya M. Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects. Clin. Chim. Acta. 2001;314:261–264
  9. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin injection. Arterioscler. Thromb. Vasc. Biol. 1995;15:1086–1093
  10. Clement K, Lahlou N, Ruiz J, Hager J, Bougners P, Basdevent A, et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int. J. Obes. Relat. Metab. Disord. 1997;21:556–561
  11. Wasada T. Diabetic ketoacidosis in type 2 diabetes mellitus. Intern. Med. 2000;39:1
  12. Nagasaka S, Ishikawa S, Itabashi N, Rokkaku K, Saito T. Ketoacidosis-onset type 2 diabetes in Japanese. Association with the widespread distribution of soft drinks and vending machines. Diabetes Care. 1998;21:1376–1378
  13. Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men (Letter). Diabetic Care. 1996;19:671
  14. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type I diabetes mellitus characterized by a rapid onset and an absence of diabetes related antibodies. New Engl. J. Med. 2000;342:301–307

PII: S0168-8227(02)00157-2

Diabetes Research and Clinical Practice
Volume 58, Issue 3 , Pages 167-172 , December 2002